The case for mild stimulation for IVF: recommendations from The International Society for Mild Approaches in Assisted Reproduction

Reprod Biomed Online. 2022 Dec;45(6):1133-1144. doi: 10.1016/j.rbmo.2022.07.019. Epub 2022 Aug 5.

Abstract

The practice of ovarian stimulation for IVF is undergoing a fundamental re-evaluation as recent data begin to successfully challenge the traditional paradigm that ovarian stimulation should be aimed at the retrieval of as many oocytes as possible, in the belief that this will increase pregnancy rates. An opposing view is that live birth rate should not be the only end-point in evaluating the success of IVF treatment and that equal emphasis should be placed on safety and affordability. The International Society for Mild Approaches in Assisted Reproduction (ISMAAR) committee has carried out an up-to-date literature search, with the evidence being graded according to the University of Oxford's Centre for Evidence-Based Medicine. The recommendations were formulated taking into account the quality of evidence on the efficacy, risk and cost of each intervention. ISMAAR recommends adopting a mild approach to ovarian stimulation in all clinical settings as an increasing body of evidence suggests that mild stimulation is as effective as conventional stimulation, while being safer and less expensive. Mild ovarian stimulation could replace conventional stimulation, thus making IVF safer and more accessible worldwide.

Keywords: ISMAAR; IVF; Mild IVF; Mild ovarian stimulation.

Publication types

  • Review

MeSH terms

  • Birth Rate
  • Female
  • Fertilization in Vitro*
  • Humans
  • Ovulation Induction*
  • Pregnancy
  • Pregnancy Rate
  • Reproduction